Alteration by 2,3,7,8-tetrachlorodibenzo-p-dioxin of CCAAT/enhancer binding protein correlates with suppression of adipocyte differentiation in 3T3-L1 cells

Molecular Pharmacology

Volumn 49, Issue 6, 1996, Pages 989-997

  Liu, Phillip C C ^a   Phillips, Marjorie A ^a   Matsumura, Fumio ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; ENERGY TRANSFER; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE;

3T3 CELLS; ADIPOCYTES; ANIMALS; BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; DNA; DNA-BINDING PROTEINS; MICE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; RNA, MESSENGER; STEM CELLS; TETRACHLORODIBENZODIOXIN;

EID: 0029939543     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Poland, A., and J. C. Knutson. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examinations of their mechanisms of toxicity. Annu. Rev. Pharmacol. Toxicol. 22:517-554 (1982).
2. Hankinson, O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35:307-340 (1995).
3. Gasiewicz, T. A., and R A. Neal. 2,3,7,8-Tetrachlorodibenzo-p-dioxin tissue distribution, excretion and effect on clinical chemical parameters in guinea pigs. Toxicol Appl. Pharmacol. 51:329-339 (1979).
4. Chapman, D. E., and C. M. Schiller. Dose-related effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J and DBA/2J mice. Toxicol. Appl. Pharmacol. 78:147-157 (1985).
5. Brewster, D. W., and F. Matsumura. Reduction of adipose tissue lipoprotein lipase activity as a result of in vivo administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin to the guinea pig. Biochem. Pharmacol. 37: 2247-2253 (1988).
6. Potter, C. L., L. A. Menahan, and R. E. Peterson. Relationship of alterations in energy metabolism to hypophagia in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam. Appl. Toxicol. 6:89-97 (1986).
7. Weber, L. W. D., M. Lebofsky, H. Greim, and K. Rozman. Key enzymes of gluconeogenesis are dose-dependently reduced in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats. Arch. Toxicol 65:119-123 (1991)
8. Weber, L. W. D., M Lebofsky, B. U Stahl, S. Smith, and K K. Rozman. Correlation between toxicity and effects on intermediary metabolism in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated C57BL/6J and DBA/6J mice. Toxicol. Appl. Pharmacol 131:155-162 (1995).
9. Enan, E., P. C. C. Liu, and F. Matsumura. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes reduction of glucose transporting activities in the plasma membrane of adipose tissue and pancreas from the guinea pig. J. Biol. Chem. 267:19785-19791 (1992).
10. Liu, P. C. C., and F. Matsumura. Differential effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the 'adipose-type' and 'brain-type' glucose transporters in mice. Mol. Pharmacol. 47:65-73 (1995).
11. Lakshman, M. R., S. J. Chirtel, L. L. Chambers, and P. J. Coutlakis. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on lipid synthesis and lipogenic enzymes in the rat. J. Pharmacol. Exp. Ther. 248:62-66 (1989).
12. Green, H., and O. Kehinde. Sublines of mouse 3T3 cells that accumulate lipid. Cell 1:113-116 (1974).
13. Green, H., and O. Kehinde. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion Cell 5:19-27 (1975).
14. Cornelius, P., O. A. MacDougald, and M. D. Lane. Regulation of adipocyte development. Annu. Rev. Nutr. 14:99-129 (1994).
15. Landschulz, W. H., P. F. Johnson, E Y. Adashi, B. J. Graves, and S. L. McKnight. Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev 2:786-800 (1988).
16. Christy, R. J., V. W. Yang, J. M. Ntambi, D. E. Geiman, W. H. Landschulz, A. D. Friedman, Y. Nakabeppu, T. J. Kelly, and M. D. Lane. Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes Dev. 3:1323-1335 (1989).
17. Kaestner, K. H., E. J. Christy, and M. D. Lane. Mouse insulin-responsive glucose transporter gene: characterization of the gene and trans-activation by the CCAAT/enhancer binding protein. Proc. Natl. Acad. Sci. USA 87:251-255 (1990).
18. Sameulsson, L., K. Stromberg, K. Vikman, G. Bjursell, and S. Enerbäck. The CCAAT/enhancer binding protein and its role in adipocyte differentiation: evidence for direct involvement in terminal development. EMBO J. 10:3787-3793 (1901).
19. Lin, F.-T., and M. D. Lane. Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. Genes Dev. 6:533-044 (1992)
20. Lin, F.-T., and M. D. Lane. CCAAT/enhancer-binding protein a is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc. Natl. Acad. Sci. USA 91:8757-8761 (1994).
21. Cao, Z., R. M. Umek, and S. L. McKnight. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5:1538-1552 (1991).
22. Akira, S., H. Isshiki, T. Sugita, O. Tanabe, S. Kinoshita, Y. Nishio, T. Nakajima, T. Hirano, and T. Kishimoto. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9:1897-1906 (1990).
23. Descombes, P., M. Chojkier, S. Lichtsteiner, E. Falvey, and U. Schibler. LAP, a novel member of the C/EBP gene family encodes a liver-enriched transcriptional activator protein. Genes Dev. 3:1541-1551 (1990).
24. Chang, C.-J., T.-T. Chen, H.-Y. Lei, D.-S. Chen, and S. C. Lee. Molecular cloning of a transcription factor, AGP/EBP, that belongs to members of the C/EBP family. Mol. Cell Biol 10:6642-6653 (1990).
25. Poli, V , F. P. Mancini, and R Cortese. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction defines a new family of leucine zipper proteins related to C/EBP. Cell 63:643-653 (1991).
26. Yeh, W. C., Z. Cao, M. Classon, and S. L. McKnight. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 9:168-181 (1995).
27. Tontonoz, P., E. Hu, R. A. Graves, A. I. Budavari, and B. M. Spiegelman. mPPARy2. tissue-specific of an adipocyte enhancer. Genes Dev. 8:1224-1234 (1994).
28. Graves, R. A., P. Tontonoz, and B. M. Spiegelman. Analysis of a tissue-specific enhancer: ARF6 regulates adipogenic gene expression. Mol. Cell. Biol. 12:1202-1208 (1992).
29. Tontonoz, P., E. Hu, and B. M. Spiegelman. Stimulation of adipogenesis in fibroblasts by mPPARγ2, a lipid-activated transcription factor. Cell 79: 1147-1156 (1994).
30. Phillips, M., E. Enan, P. C. C. Liu, and F. Matsnmura. Inhibition of 3T3-L1 adipose differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Cell Sci. 108:395-402 (1995).
31. McKnight, S. L., M. D. Lane, and S. Gluecksohn-Waelsch. Is CCAAT/ enhancer-binding protein a central regulator of energy metabolism? Genes Dev. 3:2021-2024 (1989).
32. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:156-159 (1987).
33. Sylvester, S. L., C. M. J. ap Rhys, J. D. Leuthy-Martindale, and N. J. Holbrook. Induction of GADD153, a CCAAT/enhancer binding protein (C/EBP)-related gene, during the acute phase response in rats. J. Biol. Chem. 269:20119-20125 (1994).
34. Dignam, J. D., R. M. Lebowitz, and R. G. Roeder. Accurate transcription initiation by RNA polymerase II in soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489 (1983).
35. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254 (1976).
36. Lavery, D. J., and U. Schibler. Circadian transcription of the cholesterol 7 alpha hydroxylase gene may involve the liver-enriched bZIP protein DBP. Genes Dev. 7:1871-1884 (1993)
37. Christy, R. J., K. H. Kaestner, D E. Geiman, and M. D. Lane. CCAAT/ enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc. Natl. Acad. Sci. USA 88: 2593-2597 (1991).
38. Dani, C., A. Doglio, E.-Z. Amri, S Bardon, P. Fort, B. Bertrand, P. Grimaldi, and G. Ailhaud. Cloning and regulation of a mRNA specifically expressed in the preadipose state. J. Biol. Chem. 264:10119-10125 (1989).
39. Descombes, P., and U. Schibler. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LEP, are translated from the same mRNA. Cell 67:569-579 (1991).
40. Lin, F.-T., O. MacDougald, A. M. Diehl, and M D. Lane. A 30 kilodalton alternative translational product of the CCAAT/enhancer binding protein a message: transcriptional activator lacking antimitotic activity. Proc. Natl. Acad. Sci. USA 90:9609-9610 (1993).
41. Ossipow, V., P. Descombes, and U. Schibler. CCAAT/enhancer binding protein mRNA is translated in to multiple proteins with different transcriptional activator potentials. Proc. Natl. Acad. Sci. USA 90:219-8223 (1993).
42. Freytag, S. O., and T. J. Geddes. Reciprocal regulation of adipogenesis by myc and C/EBPα. Science (Washington D. C.) 236:379-382 (1992).
43. Sunahara, G. I., G. W. Lucier, Z. McCoy, E. H. Bresnick, E. R. Sanchez, and K. G. Nelson. Characterization of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated decreases in dexamethasone binding to rat hepatic cytosolic glucocorticoid receptor. Mol. Pharmacol. 36:269-247 (1989).
44. Vasseur-Cognet, M., and M. D. Lane. Trans-acting factors involved in adipogenic differentiation. Curr. Opin. Genet. Dev. 3:238-245 (1993).
45. Wu, Z., Y. Xie, N. L. R. Bucher, and S. E. Farmer. Conditional ectopic expression of C/EBPβ in NIH-3T3 cells induces PPARγ and stimulates adipogenesis. Genes Dev. 9:2350-2363 (1995).
46. Gasiewicz, T. A., and G. Rucci. α-Naphthoflavone acts as an antagonist of 2,3,7,8-tetrachlorodibenzo-p-dioxin by forming an inactive complex with the Ah receptor. Mol. Pharmacol. 40:607-612 (1991).
47. Ignotz, R. A., and J. Massague Type β transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts. Proc. Natl. Acad. Sci. USA 82:8530-8534.
48. Ron, D., A. R. Brasier, R. E. McGehee, and J. F. Habener. Tumor necrosis factor-induced reversal of adipocytic phenotype of 3T3-L1 cells is preceded by a loss of nuclear CCAAT/enhancer binding protein (C/EBP). J. Clin Invest. 89:223-233 (1992).
49. Wang, N.-d., M. J. Finegold, A. Bradley, C. N. Ou, S. V. Abdelsayed, M. D. Wilde, L. R. Taylor, D. R. Wilson, and G. J. Darlington. Impaired energy homeostasis in C/EBPα knockout mice. Science (Washington D. C.) 269: 1108-1112 (1995).
50. Friedman, A. D., W. H. Landschulz, and S. L. McKnight. CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells. Genes Dev. 3:1416-1426 (1989).